We are involved in the investigation of new indications for molecules, with the aim of developing innovative therapies to improve the health of patients.
Pharmaceutical innovation is currently working as sponsor in two innovative projects that study two specifics molecules for the treatment of a series of indications for which there is currently no effective therapy: Spinal Cord Injury, post COVID fatigue and for some symptoms associated with Parkinson’s disease. We collaborate with other companies such us Sinfatín and Golden Gait Biotech to carry out these projects.
